- Home
- BKYI vs XAIR Comparison
BKYI vs XAIR Comparison
Compare BKYI & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKYI | XAIR |
|---|---|---|
| Founded | 1993 | 2011 |
| Country | United States | United States |
| Employees | N/A | 61 |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 5.7M |
| IPO Year | 2013 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BKYI | XAIR |
|---|---|---|
| Price | $0.62 | $0.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 147.3K | ★ 308.2K |
| Earning Date | 05-14-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.09 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $6,302,984.00 | $3,705,000.00 |
| Revenue This Year | $50.61 | $122.00 |
| Revenue Next Year | $33.33 | $58.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 111.81 | ★ 219.67 |
| 52 Week Low | $0.49 | $0.15 |
| 52 Week High | $1.97 | $3.78 |
Technical Indicators
Market Signals| Indicator | BKYI | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 53.87 | 34.22 |
| Support Level | $0.51 | $0.15 |
| Resistance Level | $0.63 | $0.82 |
| Average True Range (ATR) | 0.04 | 0.08 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 55.74 | 21.74 |
Price Performance
Historical ComparisonAbout BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.